UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian study

Global & regional health technology assessment (Online), 2024-01, Vol.11 (1), p.191-199

2024

Volltextzugriff (PDF)

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients

Breast cancer research and treatment, 2009-12, Vol.118 (3), p.523-530

2009

Volltextzugriff (PDF)

Metabolomics: Available Results, Current Research Projects in Breast Cancer, and Future Applications

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2840-2846

2007

Volltextzugriff (PDF)

The role of abemaciclib in treatment of advanced breast cancer

Therapeutic Advances in Medical Oncology, 2018-01, Vol.10, p.1758835918776925-1758835918776925

2018

Volltextzugriff (PDF)

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

Breast cancer research : BCR, 2019-05, Vol.21 (1), p.71-71, Article 71

2019

Volltextzugriff (PDF)

Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)

European journal of cancer (1990), 2019-06, Vol.114, p.55-66

2019

Volltextzugriff (PDF)

A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer

Clinical breast cancer, 2021-08, Vol.21 (4), p.e332-e339

2021

Volltextzugriff (PDF)

Topoisomerase II alpha as a marker predicting anthracyclines’ activity in early breast cancer patients: Ready for the primetime?

European journal of cancer (1990), 2008-12, Vol.44 (18), p.2791-2798

2008

Volltextzugriff (PDF)

The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept study

PloS one, 2013-05, Vol.8 (5), p.e62543

2013

Volltextzugriff (PDF)

MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples

Briefings in bioinformatics, 2023-03, Vol.24 (2)

2023

Volltextzugriff (PDF)

Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institution

The breast journal, 2019-11, Vol.25 (6), p.1225-1229

2019

Volltextzugriff (PDF)

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.283-289

2012

Volltextzugriff (PDF)

LEARN: a multicentre, cross‐sectional evaluation of Urology teaching in UK medical schools

BJU international, 2022-11, Vol.130 (5), p.676-687

2022

Volltextzugriff (PDF)

Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the Literature

Anticancer research, 2018-08, Vol.38 (8), p.4839-4845

2018

Volltextzugriff (PDF)

Systemic Treatment of Metastatic Breast Cancer (MBC) in Older Adults

Breast (Edinburgh), 2017-11, Vol.36, p.S24

2017

Volltextzugriff (PDF)

IN16 - Systemic Treatment of Metastatic Breast Cancer (MBC) in Older Adults

Breast (Edinburgh), 2017-11, Vol.36, p.S24-S24

2017

Volltextzugriff (PDF)

Role of serum thymidine kinase-1 (TK1) activity in patients (pts) with hormone receptor positive (HR+) advanced breast cancer (ABC) treated with endocrine therapy (ET) in the EFECT trial

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.12031-12031

2018

Volltextzugriff (PDF)

Abstract PO1-07-02: Sensitive tumor detection, accurate quantification, and ER subtyping using low-pass methylome of liquid biopsy samples from patients (pts) with metastatic breast cancer (mBC)

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO1-07-02-PO1-07-02

2024

Volltextzugriff (PDF)

International study on inter-reader variability for circulating tumor cells in breast cancer

Breast cancer research : BCR, 2014-04, Vol.16 (2), p.R43-R43, Article R43

2014

Volltextzugriff (PDF)

Abstract P3-05-45: Circulating tumor cells, immunohistochemical subtypes, and genes mutation as prognostic markers in HER2 negative metastatic breast cancer patients candidates to chemotherapy

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P3-P3-05-45

2023

Volltextzugriff (PDF)

Taxanes in the elderly: Can we gain as much and be less toxic?

Critical reviews in oncology/hematology, 2009-06, Vol.70 (3), p.262-271

2009

Volltextzugriff (PDF)

Clinical decision making in breast cancer: TAM and aromatase inhibitors for older patients - a jungle?

European journal of cancer (1990), 2007-10, Vol.43 (15), p.2270-2278

2007

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Humans
(21)
Life Sciences & Biomedicine
(21)
Female
(18)
Oncology
(18)
Breast Cancer
(14)
Breast Neoplasms - Drug Therapy
(13)
Middle Aged
(10)
Aged
(8)
Breast Neoplasms - Metabolism
(8)
Breast Neoplasms - Pathology
(8)
Tumors
(8)
Breast Neoplasms - Genetics
(7)
Hematology, Oncology And Palliative Medicine
(7)
Adult
(6)
Biological And Medical Sciences
(6)
Chemotherapy
(6)
Medical Sciences
(6)
Receptor, Erbb-2 - Metabolism
(6)
Antineoplastic Agents - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian study

ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in Italy

Adherence, persistence and treatment switching in psoriasis

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients

Metabolomics: Available Results, Current Research Projects in Breast Cancer, and Future Applications

The role of abemaciclib in treatment of advanced breast cancer

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)

A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer

Topoisomerase II alpha as a marker predicting anthracyclines’ activity in early breast cancer patients: Ready for the primetime?

The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept study

MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples

Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institution

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

LEARN: a multicentre, cross‐sectional evaluation of Urology teaching in UK medical schools

Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the Literature

Systemic Treatment of Metastatic Breast Cancer (MBC) in Older Adults

IN16 - Systemic Treatment of Metastatic Breast Cancer (MBC) in Older Adults

Role of serum thymidine kinase-1 (TK1) activity in patients (pts) with hormone receptor positive (HR+) advanced breast cancer (ABC) treated with endocrine therapy (ET) in the EFECT trial

Abstract PO1-07-02: Sensitive tumor detection, accurate quantification, and ER subtyping using low-pass methylome of liquid biopsy samples from patients (pts) with metastatic breast cancer (mBC)

International study on inter-reader variability for circulating tumor cells in breast cancer

A phase II trial of the CDK4/6 inhibitor palbociclib (P) as single agent or in combination with the same endocrine therapy (ET) received prior to disease progression, in patients (pts) with hormone receptor positive (HR+) HER2 negative (HER2−) metastatic breast cancer (mBC) (TREnd trial)

Abstract P3-05-45: Circulating tumor cells, immunohistochemical subtypes, and genes mutation as prognostic markers in HER2 negative metastatic breast cancer patients candidates to chemotherapy

Taxanes in the elderly: Can we gain as much and be less toxic?

Clinical decision making in breast cancer: TAM and aromatase inhibitors for older patients - a jungle?

Suchergebnisse filtern